References
- McCurry J. Japan deaths spark concerns over arthritis drug. Lancet. 2004;363:461.
- Ichikawa Y, Kamatani N, Goto M, Kondo H, Saito T, Suzuki Y, et al. Phase II dose ranging study of leflunomide in Japan. J New Rem & Clin. 2003;52:891–931.
- Appended document of Arava® (in Japanese). Sanofi-Aventis Japan; 2006 revised.
- Momo H, Suzuki H, Mitsuhashi H, Urata M, Nitta Y, Yasuda K. Evaluation of pharmacokinetics and safety of leflunomide (HWA486) in healthy adult men (author's translation). J New Rem & Clin. 2003;52:876–90.
- Yasuda K, Momo H, Suzuki H, Urata M, Muraki S, Mitsuhashi H. Study of removal therapy of active metabolite (A771726) of leflunomide (HWA486) by colestyramine (author's translation). J New Rem & Clin. 2003;52:85–94.
- Strand V, Cohen S, Schiff M, Weaver A, Fleischmann R, Cannon G, et al. Treatment of active rheumatoid arthritis with lefluno-mide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. Arch Intern Med. 1999;159:2542–50.
- Smolen JS, Kalden JR, Scott DL, Rozman B, Kvien TK, Larsen A, et al. Efficacy and safety of leflunomide compared with pla-cebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group. Lancet. 1999;353:259–66.
- Roman B. Clinical experience with leflunomide in rheumatoid arthritis. Leflunomide Investigators' Group. J Rheumatol.. 1998;53 (Suppl):27.
- Prakash A, Jarvis B. Leflunomide—a review of its use in active rheumatoid arthritis. Drugs. 1999;58:1137–64.
- Sawada T, Inokuma S, Sato T, Sagawa A, Matsuda T, Takemura T, et al. Leflunomide-induced lung diseases: overview of its occurrence, and identification of risk factors. Mod Rheumatol. 2007;17(Suppl):99.
- Sato T, Inokuma S, Sagawa A, Matsuda T, Ohtsuka T, Saeki Y, et al. Analysis of rheumatoid arthritis patients of died of and recovered from leflunomide-induced interstitial pneumonia. Mod Rheumatol. 2007;17(Suppl):100.
- Hirabayashi Y, Shimizu H, Kobayashi N, Kudo K. Leflunomide-induced pneumonitis in a patient with rheumatoid arthritis. Intern Med. 2006;45:689–91.
- Study Group of the Ministry of Health, Labour and Welfare. Therapeutic manual of rheumatoid arthritis (revised). Diagnostic manual and evidence-based treatment guidelines. Jpn Rheum Found; 2004.
- Inokuma S, Kono H, Kohno Y, Hiramatsu K, Ito K, Shiratori K, et al. Methotrexate-induced lung injury in patients with rheu-matoid arthritis occurs with peripheral blood lymphocyte count decrease. Ann Rheum Dis. 2006;65:1113–4.